Publication:
Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.

Simple item page
dc.contributor.authorLópez-Cano, Carolina
dc.contributor.authorCiudin, Andreea
dc.contributor.authorSánchez, Enric
dc.contributor.authorTinahones, Francisco J
dc.contributor.authorBarbé, Ferran
dc.contributor.authorDalmases, Mireia
dc.contributor.authorGarcía-Ramírez, Marta
dc.contributor.authorSoto, Alfonso
dc.contributor.authorGaeta, Anna Michela
dc.contributor.authorPellitero, Silvia
dc.contributor.authorMartí, Raquel
dc.contributor.authorHernández, Cristina
dc.contributor.authorSimó, Rafael
dc.contributor.authorLecube, Albert
dc.date.accessioned2023-05-03T13:38:23Z
dc.date.available2023-05-03T13:38:23Z
dc.date.issued2022
dc.description.abstractTo evaluate the effect of liraglutide, a glucagon-like peptide 1 receptor agonist, on pulmonary function and serum levels of surfactant protein D (SP-D) in type 2 diabetes. A double-blind, randomized, crossover, placebo-controlled clinical trial comprising 76 patients with a baseline forced expiratory volume in 1 s
dc.identifier.doi10.2337/db21-0688
dc.identifier.essn1939-327X
dc.identifier.pmid34737187
dc.identifier.unpaywallURLhttps://diabetesjournals.org/diabetes/article-pdf/71/2/315/640899/db210688.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20499
dc.issue.number2
dc.journal.titleDiabetes
dc.journal.titleabbreviationDiabetes
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number315-320
dc.pubmedtypeClinical Trial, Phase II
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeRandomized Controlled Trial
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subject.meshAged
dc.subject.meshBlood Glucose
dc.subject.meshCross-Over Studies
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshDouble-Blind Method
dc.subject.meshFemale
dc.subject.meshGlycemic Control
dc.subject.meshHumans
dc.subject.meshLiraglutide
dc.subject.meshLung
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPulmonary Surfactant-Associated Protein D
dc.subject.meshSpain
dc.subject.meshVital Capacity
dc.titleLiraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number71
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
SAS - Hospital Regional Universitario de Málaga

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía